SC 13G/A: Trevi Therapeutics, Inc.

AI Summary

SC 13G/A filing by Trevi Therapeutics, Inc..

Risk Assessment

Risk Level: low

Filing Documents

• d869859dsc13ga.htm (SC 13G/A) — 238KB
• d869859dex99a.htm (EX-99.A) — 21KB
• 0001193125-24-251791.txt ( ) — 261KB

From the Filing

SC 13G/A 1 d869859dsc13ga.htm SC 13G/A SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G U NDER THE S ECURITIES E XCHANGE A CT OF 1934 (Amendment No. 2)* Trevi Therapeutics, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 89532M101 (CUSIP Number) September 30, 2024 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: Rule 13d-1(b) Rule 13d-1(c) Rule 13d-1(d) * The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes ). CUSIP No. 89532M101 1. Names of Reporting Persons Frazier Life Sciences Public Fund, L.P. 2. Check the Appropriate Box if a Member of a Group (see instructions) (a)(b) 3. SEC USE ONLY 4. Citizenship or Place of Organization Delaware Number of Shares Beneficially Owned by Each Reporting Person With: 5. Sole Voting Power 0 shares 6. Shared Voting Power 5,646,596 shares (1) 7. Sole Dispositive Power 0 shares 8. Shared Dispositive Power 5,646,596 shares (1) 9. Aggregate Amount Beneficially Owned by Each Reporting Person 5,646,596 shares (1) 10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (see instructions) 11. Percent of Class Represented by Amount in Row 9 7.8% (2) 12. Type of Reporting Person (see instructions) PN (1) Consists of 5,646,596 shares of Common Stock held directly by Frazier Life Sciences Public Fund, L.P. FHMLSP, L.P. is the general partner of Frazier Life Sciences Public Fund, L.P. and FHMLSP, L.L.C. is the general partner of FHMLSP, L.P. Patrick J. Heron, James N. Topper, Albert Cha and James Brush are the members of FHMLSP, L.L.C. and therefore share voting and investment power over the shares held by Frazier Life Sciences Public Fund, L.P. (2) Based on 72,591,917 shares of Common Stock outstanding on July 31, 2024, as set forth in the Issuers Form 10-Q filed with the SEC on August 8, 2024. CUSIP No. 89532M101 1. Names of Reporting Persons FHMLSP, L.P. 2. Check the Appropriate Box if a Member of a Group (see instructions) (a)(b) 3. SEC USE ONLY 4. Citizenship or Place of Organization Delaware Number of Shares Beneficially Owned by Each Reporting Person With: 5. Sole Voting Power 0 shares 6. Shared Voting Power 5,646,596 shares (1) 7. Sole Dispositive Power 0 shares 8. Shared Dispositive Power 5,646,596 shares (1) 9. Aggregate Amount Beneficially Owned by Each Reporting Person 5,646,596 shares (1) 10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (see instructions) 11. Percent of Class Represented by Amount in Row 9 7.8% (2) 12. Type of Reporting Person (see instructions) PN (1) Consists of 5,646,596 shares of Common Stock held directly by Frazier Life Sciences Public Fund, L.P. FHMLSP, L.P. is the general partner of Frazier Life Sciences Public Fund, L.P. and FHMLSP, L.L.C. is the general partner of FHMLSP, L.P. Patrick J. Heron, James N. Topper, Albert Cha and James Brush are the members of FHMLSP, L.L.C. and therefore share voting and investment power over the shares held by Frazier Life Sciences Public Fund, L.P. (2) Based on 72,591,917 shares of Common Stock outstanding on July 31, 2024, as set forth in the Issuers Form 10-Q filed with the SEC on August 8, 2024. CUSIP No. 89532M101 1. Names of Reporting Persons FHMLSP, L.L.C. 2. Check the Appropriate Box if a Member of a Group (see instructions) (a)(b) 3. SEC USE ONLY 4. Citizenship or Place of Organization Delaware Number of Shares Beneficially Owned by Each Reporting Person With: 5. Sole Voting Power 0 shares 6. Shared Voting Power 5,646,596 shares (1) 7. Sole Dispositive Power 0 shares 8. Shared Dispositive Power 5,646,596 shares (1) 9. Aggregate Amount Beneficially Owned by Each Reporting Person 5,646,596 shares (1) 10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (see instructions) 11. Percent of Class Represented by Amount in Row 9 7.8% (2) 12. Type of Reporting Person (see instructions) OO (1) Consists of 5,646,596 shares of Common Stock held directly by Frazier Life Sciences Public Fund, L.P. FHMLSP, L.P. is the general partner of Frazier Life Sciences Public Fund, L.P. and FHMLSP, L.L.C. is the general partner of FHMLSP, L.P. Patrick J. Heron, James N. Topper, Albe

View Full Filing

View this SC 13G/A filing on SEC EDGAR